Chronic spontaneous urticaria exacerbation in a patient with COVID-19: rapid and excellent response to omalizumab.
Int J Dermatol
; 59(10): 1294-1295, 2020 Oct.
Article
in English
| MEDLINE | ID: covidwho-721133
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Anti-Allergic Agents
/
Symptom Flare Up
/
Omalizumab
/
Chronic Urticaria
/
COVID-19
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Topics:
Long Covid
Limits:
Female
/
Humans
/
Middle aged
Language:
English
Journal:
Int J Dermatol
Year:
2020
Document Type:
Article
Affiliation country:
Ijd.15134
Similar
MEDLINE
...
LILACS
LIS